Bone Biologics BBLG
NASDAQ BBLG
$0.47 -0.02 (-4.29%)
At close: Oct 1, 2026 · 4:00 PM EDT

Bone Biologics (BBLG) Long-Term Debt Repayments (2013 - 2021)

Updated

Bone Biologics' Long-Term Debt Repayments was $10,609 in Q1 2021.

Analysis

Bone Biologics (BBLG) Long-Term Debt Repayments (2013 - 2021) Analysis & Trends

On a trailing twelve-month basis, Bone Biologics' Long-Term Debt Repayments was $329,803 through Mar 31, 2021; for FY2018, it came in at $600,000.

  • Long-Term Debt Repayments shows a four-year compound annual growth rate of 0.4% (FY2014 to FY2018).
  • In earlier years, Long-Term Debt Repayments was $590,000 in FY2014.
  • The Q1 2021 figure marks the highest quarterly Long-Term Debt Repayments since Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 1.41 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 2.00 Bn
10 Bone Biologics 905,190.00 905,190.00 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 10,609.00
Dec 31, 2014 324,188.00
Jul 31, 2013 -4,994.00
API Access

Bone Biologics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=BBLG&period=max&api_key=YOUR_API_KEY